'Rbv' presentation slideshows

Sofosbuvir ( Sovaldi )

Sofosbuvir ( Sovaldi ). Prepared by: David Spach, MD & H. Nina Kim, MD Last Updated: July 14, 2015. Sofosbuvir ( Sovaldi ). Background and Dosing. Sofosbuvir ( Sovaldi ). Approval Status : FDA approved December 6, 2013

2.02k views • 194 slides

How to Optimize Treatment of non G1 Patients

Luncheons PHC Paris January 31, 2012. How to Optimize Treatment of non G1 Patients. Alessandra Mangia S. Giovanni Rotondo ITALY. March 14, 2011. 49 years old man, BMI: 28 HCV diagnosed in 1998 - previous iv drug and alcohol user - genotype 3, HCVRNA:410.000 IU/ml

503 views • 50 slides

HCV 2014 and b eyond the i nterferon era

HCV 2014 and b eyond the i nterferon era. Patrick M. Horne, MSN, ARNP, FNP-BC Assistant Director of Hepatology Clinical Research Division of Gastroenterology, Hepatology and Nutrition University of Florida Health. Disclosures and Off-label Discussion.

545 views • 37 slides

Standard Interferon vs. Pegylated Interferon

311 views • 30 slides

DYNAMIC CAPABILITIES: WHAT ARE THEY?

DYNAMIC CAPABILITIES: WHAT ARE THEY?. ???????? ?????????? ?????????? 2011/04/01. ?? dynamic capabilities ????????? RBV ????????????? RBV ?????????????????????????????????????????????????????????????????????????. DYNAMIC CAPABILITIES. ???

532 views • 13 slides

The problem statement of RBridge edge group state synchronization draft-hao-trill-rb-syn-00

233 views • 9 slides